Navigation Links
PharmaTech in Medical News

WuXi PharmaTech Appoints Dr. Chi-Chung Chan as Vice President of Pharmacology

SHANGHAI, July 23 /PRNewswire-Asia/ - WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company with operations in China and the United States, today announced that Dr. Chi-Chung Chan has been appointed...

WuXi PharmaTech Files 2008 Annual Report on Form 20-F

SHANGHAI, June 25 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ) today announced that it filed its annual report on Form 20-F for the year ended December 31, 2008 with the Securities and Exchange Commission. The annual report can be accessed on WuXi PharmaTech's website at h...

WuXi PharmaTech Announces First-Quarter 2009 Results

SHANGHAI, China, May 14 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading research and development outsourcing company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financi...

WuXi PharmaTech Appoints Hao Zhou as Vice President of Finance

SHANGHAI, May 5 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX ) today announced that it has appointed Hao Zhou as Vice President of Finance. (Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO ) Prior to joining WuXi PharmaTech, Mr. Zhou worked for eleven years at...

WuXi PharmaTech Schedules Fourth Quarter 2008 Earnings Release on Thursday, March 26, 2009

SHANGHAI, March 12 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the fourth quar...

WuXi PharmaTech Announces CFO Benson Tsang to Leave Company; COO Edward Hu Named Acting CFO

SHANGHAI, Feb. 17 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX ) announced today that Benson Tsang, Chief Financial Officer, is leaving the company for personal reasons at the end of February. Edward Hu, Chief Operating Officer, will serve as acting Chief Financial Officer until a replace...

WuXi PharmaTech Honored on the Deloitte Technology Fast 500 Asia Pacific 2008 List for the Fifth Consecutive Year

SHANGHAI, China, Feb. 8 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX ), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, is proud to announce that it was selected for the Deloitte Technol...

WuXi PharmaTech Appoints Stewart Hen and Ning Zhao to Its Board of Directors; Tao Lin Leaves Board

SHANGHAI, China, Feb. 5 /PRNewswire-Asia/ - WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company with operations in China and the United States, today announced the addition of Stewart Hen and Ning...

WuXi PharmaTech to Present at 20th Annual Piper Jaffray Healthcare Conference

SHANGHAI, China, Nov. 27 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced Edward Hu, the Company's Chief Operatin...

WuXi PharmaTech Expands Collaboration for Fully Integrated Services

SHANGHAI, China, Oct. 16 /Xinhua-PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced it has reached an agreement with J...
PharmaTech in Medical Technology

Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials

...ma, Chronic Myelogenous Leukemia, and Non-Small Cell Lung Cancer (NSCLC). pharmatech will manage the trials using its innovative JIT approach. This streamlined ...ion of approximately 165 Pharmatech Research Network sites. Matthew Wiener, pharmatech CEO, states that "The recent activity in new business has been a true testa...

Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial

... trial will also be supported by the Sarcoma Foundation of America (SFA). pharmatech will manage this sarcoma trial using its innovative Just-In-Time(TM) (JIT) ... the highest quality of clinical research, while protecting patient safety. pharmatech provides services of a Site Management Organization (SMO) and a Contract Re...

Quest PharmaTech's Prostate Cancer Program Update

...ical trial for the same indications. In addition, SL017 is currently undergoing a Canadian Phase I clinical trial for Actinic Keratosis. About Quest pharmatech Inc. The Corporation is a publicly traded , Alberta-based drug development company committed to the development and commercialization of new pharmac...
PharmaTech in Biological Technology

WuXi PharmaTech Schedules Second-Quarter 2009 Earnings Release

SHANGHAI, July 20 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the second quart...

WuXi PharmaTech Receives Award from BASF

SHANGHAI, July 1 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ) announced today that it had received an award from BASF for excellent service and outstanding contributions in the area of custom synthesis for new crop-protection active ingredients. (Logo: http://www.ne...

WuXi PharmaTech Named a Top Ten Chinese Outsourcing Enterprise

SHANGHAI, June 29 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ) announced today that it had been selected by China's Ministry of Commerce to the list of Top Ten Leading Outsourcing Enterprises in China. The list was announced at the Second Annual China International Service ...

WuXi PharmaTech Appoints Felix Hsu as Senior Vice President of U.S. Operations

SHANGHAI, June 22 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company with operations in China and the United States, today announced that Felix Hsu has been appointed Senior ...

WuXi PharmaTech Appoints Wei-Min Chang as Vice President of Operations and General Manager of SynTheAll Manufacturing Facility, Eric Gu as Vice President of Business Development for Manufacturing Services

SHANGHAI, June 21 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company with operations in China and the United States, today announced that Wei-Min Chang has been appointed Vic...

WuXi PharmaTech to Present at Third Annual Jefferies Healthcare Conference

SHANGHAI, June 16 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ) today announced that Edward Hu, the Company's Chief Operating Officer and acting Chief Financial Officer, will present at the Third Annual Jefferies Healthcare Conference in New York on Wednesday, June 17, 2009,...

WuXi PharmaTech Schedules First-Quarter 2009 Earnings Release

Earnings Conference Call to be Held on May 15, 2009 at 8:00 am (Eastern) / 5:00 am (Pacific) / 8:00 pm (Beijing/Shanghai/Hong Kong) SHANGHAI, May 1 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading pharmaceutical, biotechnology and medical device R&D outsourcing ...

WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results

SHANGHAI, March 25 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading research and development outsourcing company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financial re...

The Fitzsimons Redevelopment Authority Selects Pharmatech Oncology as Preferred Vendor

AURORA, Colo., March 18 /PRNewswire/ -- Pharmatech Oncology has been selected by the Fitzsimons Redevelopment Authority to be a preferred vendor to the Colorado Science + Technology Park at Fitzsimons. The Technology Park is home to 25 pharmaceutical and biotechnology companies. The majority of ...

Quest PharmaTech Announces Strategic Alliance with IntelligentNano to Develop Nanotechnology-Based Next Generation SL052

TSX Venture: QPT EDMONTON, March 18 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or the "Company"), a pharmaceutical company developing and commercializing products for the treatment of cancer and dermatological conditions, today announced that it has formed a strategi...
Other Tags
(Date:7/29/2014)... (PRWEB) July 29, 2014 Gout was one ... lifestyles have proven that last statement essentially moot since ... many people still do not have are the resources to ... is it costly to maintain treatment for it, but the ... daily activities to a grinding halt. , Alternative ...
(Date:7/29/2014)... 2014 Couples rule at Maui's only Forbes ... This September through November, the focus is on activities ... couples of all ages and interests. Best of all, ... of the Resort's popular Experience More package , with ... sale" is in full swing in the award-winning restaurants, spa ...
(Date:7/29/2014)... his latest blog post at http://www.perwickstrom.com , entrepreneur, author, ... 6 ways to light the “fire” in employees. , “Employers ... for some it’s a losing battle,” commented Per Wickstrom ... help employees get to the next level; which not only ... to Per Wickstrom, 6 ways to light the “fire” in ...
(Date:7/29/2014)... Nuanced Media, a leading digital marketing ... (Health Insurance Portability and Accountability Act) certified firm. ... and transfer of Personal Health Information (PHI). By ... Media can effectively serve their medical industry clients. , ... offer medical industry specific products such as medical ...
(Date:7/28/2014)... July 29, 2014 Treat skin to a ... Sublime Beauty®. , Today and tomorrow only (while supplies last), ... "The cleanser is ideal for two specific users: , 1) ... unclogged and bacteria free, and , 2) aging skin to ... says Kathy Heshelow, founder of Sublime Beauty®. , Those with ...
Breaking Medicine News(10 mins):Health News:Gout Natural Remedy Report Review | The Ultimate Secret to Eliminating Gout Naturally – Vinamy.com 2Health News:Four Seasons Resort Maui at Wailea Goes All Out to Give Couples Memorable Get-Away this Fall at Maui’s Luxury Resort 2Health News:Four Seasons Resort Maui at Wailea Goes All Out to Give Couples Memorable Get-Away this Fall at Maui’s Luxury Resort 3Health News:Per Wickstrom’s Latest Blog Post Lists 6 Ways to Light the “Fire” in Employees 2Health News:Nuanced Media Web Design Agency Now Hipaa Certified 2Health News:Clear, Clean Skin With the New Salicylic Wash from Sublime Beauty®; Enlivens Skin, Unclogs Pores 2
(Date:7/28/2014)... and other forms of dementia, but the research community ... of Washington bioengineers have a designed a peptide structure ... normal proteins into a state that,s linked to widespread ... diabetes and Lou Gehrig,s disease. The synthetic molecule blocks ... into an abnormally folded form by targeting a toxic ...
(Date:7/28/2014)... St. Jude Children,s Research Hospital study found that 73 ... doubled their risk of developing metabolic syndrome and related ... The results appear in the current issue of the ... the 1,598 adult survivors of childhood cancer in the ... risk factors like high blood pressure, abdominal obesity, elevated ...
(Date:7/28/2014)... Research and Markets has announced ... America 2014-2018" report to their offering. ... and analyze biological data. These systems capture biological traits ... patterns, and hand measurements from the subject and compare ... main purpose of a biometrics system is to identify ...
Breaking Biology News(10 mins):New protein structure could help treat Alzheimer's, related diseases 2New protein structure could help treat Alzheimer's, related diseases 3Unhealthy habits more than double risk of metabolic syndrome in childhood cancer survivors 2Unhealthy habits more than double risk of metabolic syndrome in childhood cancer survivors 3Biometrics Market in Latin America 2014-2018 2
Other Contents